US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Franklin Genomic Advancements ETF

38.86

+0.00290.01%

Post-market: 38.860.00000.00%16:10 EDT

Volume:2K

Turnover:77.85K

Market Cap:29.14M

PE:- -

High:39.33

Open:39.33

Low:38.75

Close:38.85

52wk High:41.30

52wk Low:27.54

Shares:750.00K

Float Shares:750.00K

Volume Ratio:1.23

T/O Rate:0.27%

Dividend:0.14

Dividend Rate:0.37%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Natera’s New ctDNA-Guided Immunotherapy Trial Could Redefine Cancer Treatment Cycles

Adaptive Biotechnologies CSO Harlan S. Robins Reports Disposal of Common Shares Worth $10.77 Million

Krystal Biotech Updates Financial Calendar with Quarterly Results Release, Conference Call

Natera (NTRA) Gets a Buy from BTIG

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HELX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HELX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","market":"US","secType":"STK","nameCN":"Franklin Genomic Advancements ETF","latestPrice":38.8569,"timestamp":1785182400000,"preClose":38.854,"halted":0,"volume":1991,"hourTrading":{"tag":"盘后","latestPrice":38.8569,"preClose":38.8569,"latestTime":"16:10 EDT","volume":7,"amount":271.99830000000003,"timestamp":1785183004632,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.00007463838986986924,"floatShares":750000,"shares":750000,"eps":0,"marketStatus":"Post-Mkt","change":0.0029,"latestTime":"07-27 17:04:12 EDT","open":39.33,"high":39.3301,"low":38.75,"amount":77845,"amplitude":0.01493,"askPrice":58.39,"askSize":200,"bidPrice":19.47,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1785196800000},"marketStatusCode":4,"adr":0,"exchange":"CBOE","adjPreClose":38.854,"sharesOutstanding":650000,"nav":38.866,"aum":29149866.47,"dividendRate":0.003701,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.8569,"preClose":38.8569,"latestTime":"16:10 EDT","volume":7,"amount":271.99830000000003,"timestamp":1785183004632,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.225231,"impliedVol":0.0695,"impliedVolPercentile":0.0837},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HELX\",,,,,undefined,":{"symbol":"HELX","floatShares":750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.225231,"shares":750000,"dividePrice":0.1438,"high":39.3301,"amplitude":0.01493,"preClose":38.854,"low":38.75,"week52Low":27.5386,"pbRate":"--","week52High":41.3,"institutionHeld":0,"latestPrice":38.8569,"eps":0,"divideRate":0.003701,"volume":1991,"delay":0,"ttmEps":0,"open":39.33,"prevYearClose":36.3062,"prevWeekClose":38.854,"prevMonthClose":39.9651,"prevQuarterClose":39.9651,"fiveDayClose":38.4649,"twentyDayClose":39.4165,"sixtyDayClose":32.5702},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HELX\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HELX","amount":0.14334,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Franklin Genomic Advancements ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-08","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-08"},{"market":"US","date":"2021-12-30","symbol":"HELX","amount":0.003935,"defaultRemindTime":1640874600000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000},{"market":"US","date":"2021-12-13","symbol":"HELX","amount":0.114148,"defaultRemindTime":1639405800000,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2021-12-21","payableDate":"2021-12-14","currency":"USD","type":"dividend","dateTimestamp":1639371600000},{"market":"US","date":"2020-12-14","symbol":"HELX","amount":0.005005,"name":"FRANKLIN GENOMIC ADVANCEMENTS ETF","recordDate":"2020-12-23","payableDate":"2020-12-15","currency":"USD","type":"dividend","dateTimestamp":1607922000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HELX\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-23","value":0.005005,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-21","value":0.114148,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.003935,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-08","value":0.14334,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HELX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HELX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654036232","title":"Natera’s New ctDNA-Guided Immunotherapy Trial Could Redefine Cancer Treatment Cycles","url":"https://stock-news.laohu8.com/highlight/detail?id=2654036232","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654036232?lang=en_us&edition=fundamental","pubTime":"2026-07-25 00:33","pubTimestamp":1784910804,"startTime":"0","endTime":"0","summary":"Natera Inc. ($NTRA) announced an update on their ongoing clinical study. Natera, Inc. has launched a new trial titled “A Multicenter Randomized Ope...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nateras-new-ctdna-guided-immunotherapy-trial-could-redefine-cancer-treatment-cycles?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nateras-new-ctdna-guided-immunotherapy-trial-could-redefine-cancer-treatment-cycles?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NTRA","GNOM","LU0012050646.USD","LU2065170008.USD","LU2065171402.SGD","BK4139","LU2324357040.USD","LU1988902786.USD","LU2065171311.SGD","LU2264538146.SGD","LU0106261612.USD","LU0345770308.USD","LU1064131342.USD","LU2065731478.USD","HELX","LU2065169927.USD","LU0963586101.USD","LU0345770993.USD","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653774168","title":"Adaptive Biotechnologies CSO Harlan S. Robins Reports Disposal of Common Shares Worth $10.77 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2653774168","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653774168?lang=en_us&edition=fundamental","pubTime":"2026-07-24 07:35","pubTimestamp":1784849727,"startTime":"0","endTime":"0","summary":"Adaptive Biotechnologies CSO Harlan S. Robins reports disposal of common shares worth $10.77 millionAdaptive Biotechnologies Chief Scientific Officer Harlan S. Robins exercised options for 284,800 com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL5cmyfR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Adaptive Biotechnologies CSO Harlan S. Robins Reports Disposal of Common Shares Worth $10.77 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELX","BK4121","ADPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653776725","title":"Krystal Biotech Updates Financial Calendar with Quarterly Results Release, Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2653776725","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653776725?lang=en_us&edition=fundamental","pubTime":"2026-07-24 05:01","pubTimestamp":1784840492,"startTime":"0","endTime":"0","summary":"Krystal Biotech updates financial calendar with quarterly results release, conference callSecond-quarter 2026 financial results scheduled for release on Aug. 3, 2026, before the U.S. market open.Confe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL3BPkQn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELX","IE00BN0W2T93.GBP","NDAQ","BK4588","SG9999014021.USD","BK4139","PSCH","IE00B3QW5Z07.USD","BK4585","IE00B64PRP62.GBP","BK4112","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU2095319765.USD","SG9999014013.SGD","IE00BKPKM429.USD","LU2210150020.SGD","BCDF","IE00BGHQF748.EUR","SG9999014005.SGD","SG9999014039.USD","KRYS","LU2210149790.SGD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653659747","title":"Natera (NTRA) Gets a Buy from BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2653659747","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653659747?lang=en_us&edition=fundamental","pubTime":"2026-07-23 19:38","pubTimestamp":1784806705,"startTime":"0","endTime":"0","summary":"BTIG analyst Mark Massaro maintained a Buy rating on Natera yesterday and set a price target of $290.00. The company’s shares closed yesterday at $...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/natera-ntra-gets-a-buy-from-btig-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/natera-ntra-gets-a-buy-from-btig-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HELX","LU2264538146.SGD","LU2065171311.SGD","BK4139","LU0053671581.USD","LU0345770308.USD","GNOM","LU2324357040.USD","LU1988902786.USD","LU1064131342.USD","LU2065170008.USD","LU0963586101.USD","LU2065169927.USD","NTRA","LU0012050646.USD","LU2065731478.USD","LU0345770993.USD","LU2065171402.SGD","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":20,"pageCount":1,"totalSize":78,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/HELX\",params:#limit:6,delay:false,,,undefined,":[]}}